1-3 of 3
Adrian Woolfson, BM BCh, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effectively Targeting Treatment-Naïve CML Stem/Progenitor Cells From Imatinib-Nonresponders With Combination Treatments Of JAK2 and ABL Inhibitors In Vitro and In Vivo

Hanyang Lin, MSc, Min Chen, PhD, Katharina Rothe, MSc, Matthew V Lorenzi, PhD, Adrian Woolfson, BM BCh, PhD, Xiaoyan Jiang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1474.
https://doi.org/10.1182/blood.V122.21.1474.1474
Published: 2013
Journal Articles

BMS-911543, A Selective JAK2 Inhibitor: A Multicenter Phase 1/2a Study In Myelofibrosis

Animesh Pardanani, MBBS, PhD, Andrew W. Roberts, MBBS, PhD, John F. Seymour, MBBS, FRACP, PhD, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Srdan Verstovsek, MD, PhD, Hagop M. Kantarjian, MD, Kebede Begna, MD, Hiroyuki Yoshitsugu, PhD, Toni Ann Gestone, PhD, Penny Phillips, PhD, Guan Xing, PhD, Gerson Peltz, MD, MPH, Matthew V Lorenzi, PhD, Leila Alland, MD, Adrian Woolfson, BM BCh, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2013) 122 (21): 664.
https://doi.org/10.1182/blood.V122.21.664.664
Published: 2013
Journal Articles

Targeting Treatment-Naïve CML Stem/Progenitor Cells From Imatinib-Nonresponders with JAK2 (BMS-911543)/ABL Inhibitor Combination Therapy

Hanyang Lin, Katharina Rothe, Matthew V Lorenzi, PhD, Adrian Woolfson, BM BCh, PhD, Xiaoyan Jiang, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1339.
https://doi.org/10.1182/blood.V120.21.1339.1339
Published: 2012